Investing.com - Bluejay Diagnostics (NASDAQ: BJDX) reported first quarter EPS of $-0.12, $0.06 worse than the analyst estimate of $-0.06. Revenue for the quarter came in at $809K versus the consensus estimate of $809K.
Bluejay Diagnostics's stock price closed at $0.29. It is down -58.57% in the last 3 months and down -74.76% in the last 12 months.
Bluejay Diagnostics saw positive EPS revisions and negative EPS revisions in the last 90 days. See Bluejay Diagnostics's stock price’s past reactions to earnings here.
According to InvestingPro, Bluejay Diagnostics's Financial Health score is "weak performance".
Check out Bluejay Diagnostics's recent earnings performance, and Bluejay Diagnostics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar